Mélanie Arboléas

550 total citations
11 papers, 420 citations indexed

About

Mélanie Arboléas is a scholar working on Pharmacology, Plant Science and Insect Science. According to data from OpenAlex, Mélanie Arboléas has authored 11 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 6 papers in Plant Science and 4 papers in Insect Science. Recurrent topics in Mélanie Arboléas's work include Pesticide Exposure and Toxicity (6 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Insect and Pesticide Research (4 papers). Mélanie Arboléas is often cited by papers focused on Pesticide Exposure and Toxicity (6 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Insect and Pesticide Research (4 papers). Mélanie Arboléas collaborates with scholars based in France, New Zealand and United States. Mélanie Arboléas's co-authors include Pierre‐Yves Renard, Ludovic Jean, Florian Nachon, Julien Renou, Rachid Baati, Mélanie Loiodice, Maria Kliachyna, Guillaume Mercey, Tristan Verdelet and Tiphaine Mannic and has published in prestigious journals such as PLoS ONE, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Mélanie Arboléas

11 papers receiving 418 citations

Peers

Mélanie Arboléas
Mélanie Arboléas
Citations per year, relative to Mélanie Arboléas Mélanie Arboléas (= 1×) peers Qiang Bian

Countries citing papers authored by Mélanie Arboléas

Since Specialization
Citations

This map shows the geographic impact of Mélanie Arboléas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Arboléas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Arboléas more than expected).

Fields of papers citing papers by Mélanie Arboléas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélanie Arboléas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Arboléas. The network helps show where Mélanie Arboléas may publish in the future.

Co-authorship network of co-authors of Mélanie Arboléas

This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Arboléas. A scholar is included among the top collaborators of Mélanie Arboléas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Arboléas. Mélanie Arboléas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Valat, Anne, Laure Fourel, Paul Machillot, et al.. (2023). Interplay between integrins and cadherins to control bone differentiation upon BMP-2 stimulation. Frontiers in Cell and Developmental Biology. 10. 1027334–1027334. 8 indexed citations
3.
Renou, Julien, José Dias, Guillaume Mercey, et al.. (2016). Synthesis and in vitro evaluation of donepezil-based reactivators and analogues for nerve agent-inhibited human acetylcholinesterase. RSC Advances. 6(22). 17929–17940. 31 indexed citations
4.
Mazzaferro, Silvia, J. Lavaud, Laetitia Vanwonterghem, et al.. (2015). Targeting CD44 receptor-positive lung tumors using polysaccharide-based nanocarriers: Influence of nanoparticle size and administration route. Nanomedicine Nanotechnology Biology and Medicine. 12(4). 921–932. 53 indexed citations
5.
Kliachyna, Maria, Gianluca Santoni, Julien Renou, et al.. (2014). Design, synthesis and biological evaluation of novel tetrahydroacridine pyridine- aldoxime and -amidoxime hybrids as efficient uncharged reactivators of nerve agent-inhibited human acetylcholinesterase. European Journal of Medicinal Chemistry. 78. 455–467. 69 indexed citations
6.
Renou, Julien, Mélanie Loiodice, Mélanie Arboléas, et al.. (2014). Tryptoline-3-hydroxypyridinaldoxime conjugates as efficient reactivators of phosphylated human acetyl and butyrylcholinesterases. Chemical Communications. 50(30). 3947–3950. 43 indexed citations
7.
Bouillet, Laurence, Alban Deroux, Adama Sidibé, et al.. (2013). Auto-antibodies to vascular endothelial cadherin in humans: association with autoimmune diseases. Laboratory Investigation. 93(11). 1194–1202. 17 indexed citations
8.
Vilgrain, Isabelle, Adama Sidibé, Francine Cand, et al.. (2013). Evidence for Post-Translational Processing of Vascular Endothelial (VE)-Cadherin in Brain Tumors: Towards a Candidate Biomarker. PLoS ONE. 8(12). e80056–e80056. 20 indexed citations
9.
Renou, Julien, Guillaume Mercey, Tristan Verdelet, et al.. (2012). Syntheses and in vitro evaluations of uncharged reactivators for human acetylcholinesterase inhibited by organophosphorus nerve agents. Chemico-Biological Interactions. 203(1). 81–84. 46 indexed citations
10.
Mercey, Guillaume, Julien Renou, Tristan Verdelet, et al.. (2012). Phenyltetrahydroisoquinoline–Pyridinaldoxime Conjugates as Efficient Uncharged Reactivators for the Dephosphylation of Inhibited Human Acetylcholinesterase. Journal of Medicinal Chemistry. 55(23). 10791–10795. 48 indexed citations
11.
Sidibé, Adama, Tiphaine Mannic, Mélanie Arboléas, et al.. (2011). Soluble VE‐cadherin in rheumatoid arthritis patients correlates with disease activity: Evidence for tumor necrosis factor α–induced VE‐cadherin cleavage. Arthritis & Rheumatism. 64(1). 77–87. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026